Andrea B Apolo

20PUBLICATIONS

163CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersCancer cell biologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (20)

Sort by Publication Date:

|May 16, 2026

TROPION-Urothelial03: a phase II/III study of datopotamab deruxtecan (Dato-DXd) for locally advanced or metastatic urothelial carcinoma.

|Dec 13, 2025

Advanced Urologic Cancer Consensus Conference (AUC3) 2025: Expert consensus on the management of renal cell and urinary tract cancers.

Rana R McKay, Sumanta Pal, Wanling Xie

|Sep 11, 2025

End Points for the Next-Generation Bladder-Sparing Perioperative Trials for Patients With Muscle-Invasive Bladder Cancer.

Andrea Necchi, Matthew D Galsky, Nazli Dizman

|Aug 16, 2025

HER2 and urothelial carcinoma: current understanding and future directions.

Daniele Raggi, Emanuele Crupi, Filippo Pederzoli

|Aug 09, 2025

Top advances of the year: Bladder cancer.

Andrea B Apolo, Saad Atiq, Andre R Kydd

|Sep 16, 2024

Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma.

Andrea B Apolo, Karla V Ballman, Guru Sonpavde

Pageof 4

Frequent Collaborators

James L Gulley

Matthew Galsky

Petros Grivas

Ashish M Kamat

Andrea Necchi

Daniel M Girardi

Thomas Powles

Guru Sonpavde

Jason Efstathiou

Rosa Nadal

Frequent Collaborators

James L Gulley

Matthew Galsky

Petros Grivas

Ashish M Kamat